GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.151 $0.151 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $0.120 $0.168
52 weeks $0.0471 $3.25

Historical Clovis Oncology prices

Date Open High Low Close Volume
2022-12-29 $0.0783 $0.0783 $0.0783 $0.0783 0
2022-12-28 $0.0783 $0.0783 $0.0783 $0.0783 0
2022-12-27 $0.0783 $0.0783 $0.0783 $0.0783 0
2022-12-23 $0.0783 $0.0783 $0.0783 $0.0783 0
2022-12-22 $0.0783 $0.0783 $0.0783 $0.0783 0
2022-12-21 $0.0783 $0.0783 $0.0783 $0.0783 0
2022-12-20 $0.0808 $0.0977 $0.0766 $0.0812 24 516 461
2022-12-19 $0.0800 $0.0920 $0.0770 $0.0860 19 780 678
2022-12-16 $0.0952 $0.110 $0.0760 $0.0800 22 992 778
2022-12-15 $0.108 $0.108 $0.0920 $0.0982 15 671 146
2022-12-14 $0.140 $0.144 $0.103 $0.106 24 439 580
2022-12-13 $0.185 $0.197 $0.125 $0.133 18 726 421
2022-12-12 $0.206 $0.275 $0.172 $0.202 28 327 640
2022-12-09 $0.222 $0.229 $0.200 $0.200 2 435 764
2022-12-08 $0.216 $0.239 $0.202 $0.222 4 019 124
2022-12-07 $0.240 $0.250 $0.223 $0.223 2 693 680
2022-12-06 $0.280 $0.291 $0.237 $0.252 4 719 040
2022-12-05 $0.310 $0.324 $0.290 $0.292 4 457 083
2022-12-02 $0.350 $0.360 $0.333 $0.344 2 682 279
2022-12-01 $0.330 $0.377 $0.320 $0.360 2 541 244
2022-11-30 $0.320 $0.350 $0.317 $0.330 1 698 950
2022-11-29 $0.340 $0.343 $0.310 $0.314 1 998 737
2022-11-28 $0.336 $0.355 $0.323 $0.340 2 075 150
2022-11-25 $0.332 $0.350 $0.321 $0.346 926 093
2022-11-23 $0.343 $0.355 $0.330 $0.340 2 325 544
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT